Literature DB >> 25815133

Adult stem-like cells in kidney.

Keiichi Hishikawa1, Osamu Takase1, Masahiro Yoshikawa1, Taro Tsujimura1, Masaomi Nangaku1, Tsuyoshi Takato1.   

Abstract

Human pluripotent cells are promising for treatment for kidney diseases, but the protocols for derivation of kidney cell types are still controversial. Kidney tissue regeneration is well confirmed in several lower vertebrates such as fish, and the repair of nephrons after tubular damages is commonly observed after renal injury. Even in adult mammal kidney, renal progenitor cell or system is reportedly presents suggesting that adult stem-like cells in kidney can be practical clinical targets for kidney diseases. However, it is still unclear if kidney stem cells or stem-like cells exist or not. In general, stemness is defined by several factors such as self-renewal capacity, multi-lineage potency and characteristic gene expression profiles. The definite use of stemness may be obstacle to understand kidney regeneration, and here we describe the recent broad findings of kidney regeneration and the cells that contribute regeneration.

Entities:  

Keywords:  CD133; CD24; ES cell; Induced pluripotent stem; Label-retaining cells; SP cells; Sca-1; Stem cell; rKS56

Year:  2015        PMID: 25815133      PMCID: PMC4369505          DOI: 10.4252/wjsc.v7.i2.490

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  49 in total

1.  The renal papilla is a niche for adult kidney stem cells.

Authors:  Juan A Oliver; Omar Maarouf; Faisal H Cheema; Timothy P Martens; Qais Al-Awqati
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

2.  Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1.

Authors:  Li-Jun Ma; Shinya Nakamura; Jean Claude Aldigier; Michele Rossini; Haichun Yang; Xiubin Liang; Ikuko Nakamura; Carmelita Marcantoni; Agnes B Fogo
Journal:  J Am Soc Nephrol       Date:  2005-02-23       Impact factor: 10.121

Review 3.  Glomerular epithelial stem cells: the good, the bad, and the ugly.

Authors:  Laura Lasagni; Paola Romagnani
Journal:  J Am Soc Nephrol       Date:  2010-09-09       Impact factor: 10.121

4.  Kinetics and characterization of initially regenerating proximal tubules in S3 segment in response to various degrees of acute tubular injury.

Authors:  Yoshihide Fujigaki; Tetsuo Goto; Masanori Sakakima; Hirotaka Fukasawa; Takehiko Miyaji; Tatsuo Yamamoto; Akira Hishida
Journal:  Nephrol Dial Transplant       Date:  2005-08-02       Impact factor: 5.992

5.  Efficacy and safety of renal tubule cell therapy for acute renal failure.

Authors:  James Tumlin; Ravinder Wali; Winfred Williams; Patrick Murray; Ashita J Tolwani; Anna K Vinnikova; Harold M Szerlip; Jiuming Ye; Emil P Paganini; Lance Dworkin; Kevin W Finkel; Michael A Kraus; H David Humes
Journal:  J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 10.121

6.  Regenerative potential of embryonic renal multipotent progenitors in acute renal failure.

Authors:  Elena Lazzeri; Clara Crescioli; Elisa Ronconi; Benedetta Mazzinghi; Costanza Sagrinati; Giuseppe Stefano Netti; Maria Lucia Angelotti; Eliana Parente; Lara Ballerini; Lorenzo Cosmi; Laura Maggi; Loreto Gesualdo; Mario Rotondi; Francesco Annunziato; Enrico Maggi; Laura Lasagni; Mario Serio; Sergio Romagnani; Gabriella Barbara Vannelli; Paola Romagnani
Journal:  J Am Soc Nephrol       Date:  2007-10-31       Impact factor: 10.121

7.  Angiotensin II type 1 receptor blockade prevents decrease in adult stem-like cells in kidney after ureteral obstruction.

Authors:  Takeshi Marumo; Keiichi Hishikawa; Yumi Matsuzaki; Naohiko Imai; Osamu Takase; Tatsuo Shimosawa; Hideyuki Okano; Toshiro Fujita
Journal:  Eur J Pharmacol       Date:  2007-07-25       Impact factor: 4.432

8.  Basic helix-loop-helix transcriptional factor MyoR regulates BMP-7 in acute kidney injury.

Authors:  Nozomu Kamiura; Junichi Hirahashi; Yumi Matsuzaki; Mana Idei; Osamu Takase; Toshiro Fujita; Tsuyoshi Takato; Keiichi Hishikawa
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-20

9.  Efficient and rapid induction of human iPSCs/ESCs into nephrogenic intermediate mesoderm using small molecule-based differentiation methods.

Authors:  Toshikazu Araoka; Shin-ichi Mae; Yuko Kurose; Motonari Uesugi; Akira Ohta; Shinya Yamanaka; Kenji Osafune
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

Review 10.  Toward the identification of a "renopoietic system"?

Authors:  Paola Romagnani
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277

View more
  4 in total

1.  Kidney-differentiated cells derived from Lowe Syndrome patient's iPSCs show ciliogenesis defects and Six2 retention at the Golgi complex.

Authors:  Wen-Chieh Hsieh; Swetha Ramadesikan; Donna Fekete; Ruben Claudio Aguilar
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

2.  Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.

Authors:  Ludovica Grassi; Romina Alfonsi; Federica Francescangeli; Michele Signore; Maria Laura De Angelis; Antonio Addario; Manuela Costantini; Elisabetta Flex; Andrea Ciolfi; Simone Pizzi; Alessandro Bruselles; Matteo Pallocca; Giuseppe Simone; Mustapha Haoui; Mario Falchi; Michele Milella; Steno Sentinelli; Paola Di Matteo; Emilia Stellacci; Michele Gallucci; Giovanni Muto; Marco Tartaglia; Ruggero De Maria; Désirée Bonci
Journal:  Cell Death Dis       Date:  2019-02-27       Impact factor: 8.469

3.  Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma.

Authors:  Rafia S Al-Lamki; Jun Wang; Jun Yang; Natalie Burrows; Patrick H Maxwell; Timothy Eisen; Anne Y Warren; Sakari Vanharanta; Simon Pacey; Peter Vandenabeele; Jordan S Pober; John R Bradley
Journal:  Oncotarget       Date:  2016-04-26

4.  Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored.

Authors:  Ju-Yoon Yoon; Craig Gedye; Joshua Paterson; Laurie Ailles
Journal:  BMC Cancer       Date:  2020-04-03       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.